IRIS KENNEDY: Open Payments
NPI 1609954148 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,814 in 88 payments from 16 companies in 2025. Trend: 2023 $4,370 · 2024 $6,080 · 2025 $6,814
Consulting: $3,840Food & beverage: $1,725Travel & lodging: $1,249
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 12 | $5,325 |
| Sumitomo Pharma America, Inc. | 26 | $491 |
| Janssen Biotech, Inc. | 10 | $192 |
| Novartis Pharmaceuticals Corporation | 11 | $175 |
| ACCORD HEALTHCARE, INC. | 6 | $98 |
| PFIZER INC. | 5 | $96 |
| Verity Pharmaceuticals Inc. | 4 | $87 |
| Dendreon Pharmaceuticals LLC | 3 | $65 |
| Caris MPI, Inc. | 3 | $62 |
| UROGEN PHARMA, INC. | 1 | $55 |
Products named: Nubeqa, ORGOVYX, ERLEADA, PLUVICTO, Camcevi, XTANDI, PROVENGE, MI CANCER SEEK.
Industry payments across AR — which companies pay providers there.
